PRODUCT OVERVIEW
NanoSphere’s initial product deployment is for the cannabinoid market, targeting both the medical marijuana market and, where legalized, the recreational usage market. NanoSphere has already partnered with a licensee in Colorado, and has launched its first award-winning cannabinoid product line, branded Evolve NanoSerum™, in the Colorado market. NanoSphere will further license its intellectual property and proprietary manufacturing method to selected cannabis cultivators, extractors and distributors on a state-by-state basis and abroad, and is currently in discussions with operators in several states to replicate the business model in Colorado. Other planned future deployments include nutraceuticals, non steroidal anti-inflammatory drugs and animal health applications.
64
PIONEERING NANO-BIOTECHNOLOGY COMPANY. WITH OVER 20 YEARS RESEARCHING AND DEVELOPING OUR PATENT-PENDING NANOSPHERE DELIVERY SYSTEM™.
PATENTED NANOSPHERE DELIVERY TECHNOLOGY™ INCREASES THE BIOAVAILABILITY AND BIOACTIVITY OF CANNABINOIDS.
NANOSPHERE HEALTH IS THE FIRST AND ONLY COMPANY TO NANO-SIZE AND ENCAPSULATE CANNABINOIDS, DRAMATICALLY CHANGING THE INDUSTRY.
Q& A
PRODUCT OVERVIEW
NanoSphere’s initial product deployment is for the cannabinoid market, targeting both the medical marijuana market and, where legalized, the recreational usage market. NanoSphere has already partnered with a licensee in Colorado, and has launched its first award-winning cannabinoid product line, branded Evolve NanoSerum™, in the Colorado market. NanoSphere will further license its intellectual property and proprietary manufacturing method to selected cannabis cultivators, extractors and distributors on a state-by-state basis and abroad, and is currently in discussions with operators in several states to replicate the business model in Colorado. Other planned future deployments include nutraceuticals, non steroidal anti-inflammatory drugs and animal health applications.
CI: Who would be your closes competitors in the cannabis space and what are your advantages versus your competitors?
NSHSF: In the cannabis space, NanoSphere’s brand of Evolve Formula has few competitors: Mary Medicinal and Apothecanna would be the largest. However, NanoSphere is the only company with a proven delivery system for cannabis. We have a pioneering nanoparticle viscoelastic NanoGel that has been clinically studied and verified through human pharmacokinetic studies to be rapidly absorbed through the mucosa. Other companies are adding ingredients for permeation. However, none have them have been proven by human research to carry THC across mucosal barriers to the systemic circulation required for effective analgesic relief.
CI: Could you give us some color on the size of your market and your estimated future market share?
NSHSF:
Cannabis Division:
Current domestic market size: $5.8B
Expected market size by 2020: $21B
NanoSphere capturing .4% of the market: $84,000,000
Nutraceutical Division:
Current domestic market size: $19B
Expected market size by 2024: $37B
NanoSphere capturing .5% of the market: $184,000,000
NSAID (non-steroidal anti-inflammatory drugs):
Current market size: $11B
Expected market size by 2020: $18B
NanoSphere Capturing .5% of the market: $90,000,000